https://www.bloomberg.com/news/arti...loods-u-s-biotech-as-beijing-chases-new-cures
China opening up its borders to pharma medication; MVP got a 2021 target for China but perhaps could move it to earlier timeline.
China has huge population and hitting that market will be a massive win. Though unsure how to protect IP, which is also a risk factor and therefore needs strong information security and legal controls around it.
Add to My Watchlist
What is My Watchlist?
